Replies to post #156978 on Biotech Values

[DewDiligence]

HSP shares fall on FDA import ban:

http://www.reuters.com/article/2013/02/14/us-hospira-outlook-idUSBRE91D0Y020130214

Injectable-drugs maker Hospira Inc withdrew the 2013 profit and revenue outlook it gave on Wednesday after the U.S. health regulator imposed an import ban on some of its products.

…The company has battled with issues as varied as presence of mold in certain injectable products, alarm failures in pumps, unresponsive touchscreens on its devices and software glitches.

Sounds like BAX a few years ago.